全文获取类型
收费全文 | 31758篇 |
免费 | 3334篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 265篇 |
儿科学 | 947篇 |
妇产科学 | 939篇 |
基础医学 | 4374篇 |
口腔科学 | 684篇 |
临床医学 | 3730篇 |
内科学 | 6744篇 |
皮肤病学 | 394篇 |
神经病学 | 2797篇 |
特种医学 | 956篇 |
外科学 | 4338篇 |
综合类 | 836篇 |
一般理论 | 24篇 |
预防医学 | 3418篇 |
眼科学 | 607篇 |
药学 | 2567篇 |
1篇 | |
中国医学 | 29篇 |
肿瘤学 | 1482篇 |
出版年
2021年 | 460篇 |
2020年 | 284篇 |
2019年 | 467篇 |
2018年 | 557篇 |
2017年 | 408篇 |
2016年 | 421篇 |
2015年 | 475篇 |
2014年 | 683篇 |
2013年 | 973篇 |
2012年 | 1476篇 |
2011年 | 1536篇 |
2010年 | 890篇 |
2009年 | 713篇 |
2008年 | 1353篇 |
2007年 | 1554篇 |
2006年 | 1442篇 |
2005年 | 1497篇 |
2004年 | 1330篇 |
2003年 | 1358篇 |
2002年 | 1217篇 |
2001年 | 914篇 |
2000年 | 925篇 |
1999年 | 792篇 |
1998年 | 355篇 |
1997年 | 299篇 |
1996年 | 279篇 |
1995年 | 320篇 |
1994年 | 303篇 |
1992年 | 654篇 |
1991年 | 596篇 |
1990年 | 590篇 |
1989年 | 604篇 |
1988年 | 524篇 |
1987年 | 560篇 |
1986年 | 461篇 |
1985年 | 540篇 |
1984年 | 456篇 |
1983年 | 385篇 |
1982年 | 339篇 |
1981年 | 297篇 |
1980年 | 290篇 |
1979年 | 436篇 |
1978年 | 370篇 |
1977年 | 269篇 |
1976年 | 299篇 |
1975年 | 269篇 |
1974年 | 337篇 |
1973年 | 351篇 |
1972年 | 306篇 |
1971年 | 280篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
Liam Masterson James Howard Jazmina Gonzalez-Cruz Christopher Jackson Catherine Barnett Lewis Overton Howard Liu Rahul Ladwa Fiona Simpson Margie McGrath Ben Wallwork Terry Jones Christian Ottensmeier Melvin L.K. Chua Chris Perry Rajiv Khanna Benedict Panizza Sandro Porceddu Matt Lechner 《International journal of cancer. Journal international du cancer》2020,146(8):2305-2314
Now is an exciting era of development in immunotherapy checkpoint inhibitors and their effect on the treatment of NPC. While the general prognosis of R/M disease is poor, immunotherapy offers some promise in a malignancy associated with EBV and characterized by a peritumoural immune infiltrate. Our study aims to review past and on-going clinical trials of monoclonal antibody therapies against the checkpoint inhibitors (e.g. PD1 and CTLA-4), in R/M NPC. All randomized and nonrandomized controlled trials involving immune checkpoint inhibitor interventions for treatment of NPC were included in the study. We utilized a validated “risk of bias” tool to assess study quality. Four separate Phase I–II trials report the potential of PD1 inhibitor treatment for patients with NPC. Within the observed groups, camrelizumab combined with chemotherapy achieved an objective response in 91% of patients as first-line treatment for metastatic NPC (PFS 68% at 1-year) but this was associated with a high rate of grade >3 adverse events (87%; CTCAE version 4.03). The remaining three studies focused on recurrent NPC disease in patients who had received at least one line of prior chemotherapy. Within this group, camrelizumab monotherapy achieved an objective response in 34% of patients (PFS 27% at 1-year; range across all three studies 20.5–34%). No NPC trial has yet reported on specific outcomes for non-PD1 checkpoint inhibitors but 11 on-going studies include alternative targets (e.g. PD-L1/CTLA-4) as combination or monotherapy treatments. In considering checkpoint immunotherapies for NPC, initial results show promise for anti-PD1 interventions. Further phase I–III trials are in progress to clarify clinical outcomes, fully determine safety profiles, and optimize drug combinations and administration schedules. 相似文献
3.
4.
Conall T. Morgan Brigitte Mueller Varsha Thakur Vitor Guerra Callaghan Jull Luc Mertens Mark Friedberg Fraser Golding Mike Seed Steven E.S. Miner Edgar T. Jaeggi Cedric Manlhiot Lynne E. Nield 《The Canadian journal of cardiology》2019,35(4):453-461
Background
The purpose of the study was to evaluate the association between fetal echocardiographic measurements and the need for intervention (primary coarctation repair, staged coarctation repair, or catheter intervention) in prenatally diagnosed coarctation of the aorta.Methods
A single-centre retrospective cohort study (2005-2015) of 107 fetuses diagnosed with suspected coarctation of the aorta in the setting of an apex-forming left ventricle and antegrade flow across the mitral and aortic valves.Results
Median gestational age at diagnosis was 32 weeks (interquartile range, 23-35 weeks). Fifty-six (52%) did not require any neonatal intervention, 51 patients (48%) underwent a biventricular repair. In univariable analysis, an increase in ascending aorta (AAo) peak Doppler flow velocity (odds ratio [OR], 1.40 [95% confidence interval [CI], 1.05-1.91] per 20 cm/s; P = 0.03) was associated with intervention. No intervention was associated with larger isthmus size (OR, 0.23; P < 0.001), transverse arch diameter (OR, 0.23; P < 0.001), and aortic (OR, 0.72; P = 0.02), mitral (OR, 0.58; P = 0.001), and AAo (OR, 0.53; P < 0.001) z-scores. In multivariable analysis, higher peak AAo Doppler (OR, 2.51 [95% CI, 1.54-4.58] per 20 cm/s; P = 0.001) and younger gestational age at diagnosis (OR, 0.81 [95% CI, 0.70-0.93] per week; P = 0.005) were associated with intervention, whereas a higher AAo z-score (OR, 0.65 [95% CI, 0.43-0.94] per z; P = 0.029) and transverse arch dimension (OR, 0.44 [95% CI, 0.18-0.97]; P = 0.05) decreased the risk of intervention.Conclusions
In prenatally suspected coarctation, the variables associated with intervention comprised smaller AAo and transverse arch size, earlier gestational age at diagnosis, and the additional finding of a higher peak AAo Doppler. 相似文献5.
Richard A. Lewis 《Journal of cataract and refractive surgery》2019,45(7):1051-1052
6.
7.
8.
9.
Mithun Sattur Clayton Korson Fraser Henderson Stephen Kalhorn 《The American journal of emergency medicine》2019,37(5):1005.e1-1005.e2
Occipital spur is an abnormal bony outgrowth of the external occipital protuberance (EOP). We describe an interesting and previously unreported case of fracture of an occipital spur following trauma. Our 20-year-old male patient was treated in the emergency department (ED) and discharged home without complication. Neurosurgical consultation was obtained but is not requisite for these injuries. Greater awareness of this unique presentation may help to expedite future emergency department treatment. 相似文献
10.